MedTrace Logo

How COVID-19 Effects to Muscle Mass Change ın ICU?

NCT05008562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2022-12-23

No results posted yet for this study

Summary

Critical illness myopathy and neuropathy are associated with prolonged mechanical ventilation, resulting in increased morbidity and mortality in intensive care units, .the investigators aimed to determine the decrease in muscle mass and risk factors that are important causes for the development of myopathy in COVID-19 (+) patients followed in intensive care unit. The study will also evaluate the relationships of patients withthe investigators intensive care-associated muscle weakness (ICU-AW) with other intensive care patient weight scores (SOFA, APACHE II, q SOFA).

Sensitivity of anthropometric measurements and ultrasonographic measurements will be compared in the evaluation of sarcopenia. The length of hospital stay, mechanical ventilation time, patient outcomes (mortality/morbidity) information of patients with COVID-19 pneumonia followed in the intensive care unit will be evaluated.

Conditions

  • SARS-CoV-2 Acute Respiratory Disease
  • Sarcopenia
  • ICU Acquired Weakness
  • Critical Illness Myopathy

Interventions

OTHER

COVID-19 RELATED MUSCLE MASS CHANGE IN THE INTENSIVE CARE UNIT

there is no interventions to the patients.

Sponsors & Collaborators

  • Ondokuz Mayıs University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-09
Primary Completion
2021-06-09
Completion
2021-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05008562 on ClinicalTrials.gov